Immunomodulator use does not prevent first loss of response to anti‐tumour necrosis factor alpha therapy in inflammatory bowel disease: long‐term outcomes in a real‐world cohort
Varma, Poornima, Rajadurai, Anton S., Holt, Darcy Q., Devonshire, David A., Desmond, Chris P., Swan, Michael P., Nathan, Debra, Shelton, Edward T., Prideaux, Lani, Sorrell, Catherine, Rusli, Ferry, Crantock, Luke R. F., Dev, Anouk, Ratnam, Dilip T., Pianko, Stephen, Moore, Gregory T.
Published in Internal medicine journal (01.06.2019)
Published in Internal medicine journal (01.06.2019)
Get full text
Journal Article